N@N

Nicole Gabreski Maintained (TVTX) at Hold with Decreased Target to $19 on, Aug 18th, 2023

Nicole Gabreski of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Decreased Target from $22 to $19 on, Aug 18th, 2023.

Nicole has made no other calls on TVTX in the last 4 months.

There are 9 other peers that have a rating on TVTX. Out of the 9 peers that are also analyzing TVTX, 0 agree with Nicole's Rating of Hold.

These are the ratings of the 9 analyists that currently disagree with Nicole

---

• Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $32 on, Monday, August 7th, 2023
• Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $26 on, Friday, July 21st, 2023
• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Tuesday, July 18th, 2023
• Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $23 on, Wednesday, June 21st, 2023
• Tyler Van Buren of "TD Cowen" Initiated at Buy and Held Target at $30 on, Monday, May 22nd, 2023
• Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, May 2nd, 2023
• Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $26 on, Tuesday, May 2nd, 2023
• Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $24 on, Tuesday, May 2nd, 2023
• Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $39 on, Tuesday, May 2nd, 2023

Contributing Sources

---